Litcius/Paper detail

Apoferritin: a potential nanocarrier for cancer imaging and drug delivery

Hanitrarimalala Veroniaina, Xiuhua Pan, Zhenghong Wu, Xiaole Qi

2021Expert Review of Anticancer Therapy21 citationsDOI

Abstract

Introduction: As a protein-based biomaterial for potential cancer targeting delivery, apoferritin has recently attracted interest.Areas covered: In this review, we discuss the development of this cage-like protein as an endogenous nanocarrier that can hold molecules in its cavity. We present the specific characterizations and formulations of apoferritin nanocarriers, and outline the recent progress of the protein as an appropriate tumor-delivery vehicle in different therapeutic strategies to treat solid tumors. Finally, we propose how the application for cancer drug repurposing delivery within apoferritin could expand cancer treatment in the future.Expert opinion: Being a ubiquitous iron storage protein that exists in many living organisms, apoferritin is promising as a cancer tumor-targeting nanocarrier. By exploiting its versatility, apoferritin could be used for cancer repurposed drug delivery and could reduce the high cost of new drug discovery development and shorten the formulation process.

Topics & Concepts

NanocarriersDrug deliveryBiopharmaceuticalCancerTargeted drug deliveryMedicineCancer therapyCancer drugsNanotechnologyDrugPharmacologyBiologyMaterials scienceBiotechnologyInternal medicineRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesNanoparticle-Based Drug Delivery